Clinical Oncology10.1016/j.clon.2017.01.0272017296e101The 21-gene Recurrence Score: Impact on Adjuvant Chemotherapy Decisions in Early Breast Cancer, West of Scotland Cancer Centre ExperienceA. Morton, I. MacPherson, H. Marashi,
SpringerPlus10.1186/2193-1801-3-71201431Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score resultsGeorgeta Fried, Mor Moskovitz,,
npj Breast Cancer10.1038/s41523-021-00231-x202171Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancerDella Makower, Juan Lin, Xiaonan Xue, Joseph A. Sparano,,
The Breast10.1016/s0960-9776(11)70141-2201120S44P200 Impact of the 21-gene recurrence score assay on treatment decision in early breast cancer (EBC) patients with favourable prognostic factorsC. Markopoulos,
The Breast10.1016/s0960-9776(17)30281-3201732S87Poor concordance between 21-gene expression assay recurrence score and all Magee equation recurrence scores in a consecutive cohort of patients treated for hormone receptor positive early breast cancerZ. Abdel-Rahman, H. Ali, L. Favazza, D. Chitale,
npj Breast Cancer10.1038/s41523-018-0082-6201841Clinical relevance of the 21-gene Recurrence ScoreĀ® assay in treatment decisions for patients with node-positive breast cancer in the genomic eraEleftherios P. Mamounas, Christy A. Russell, Anna Lau, Michelle P. Turner, Kathy S. Albain,,
Breast Cancer Research and Treatment10.1007/s10549-013-2603-12013140183-92The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patientsSalomon M. Stemmer, Shmuel H. Klang, Noa Ben-Baruch, David B. Geffen, Mariana Steiner, Lior Soussan-Gutman, Shahar Merling, Christer Svedman, Shulamith Rizel, Nicky Lieberman,,
Breast Cancer Research and Treatment10.1007/s10549-021-06228-12021Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancerMinji Koh, Jinhong Jung, Su Ssan Kim, Seung Do Ahn, Eun Kyung Choi, Il Yong Chung, Jong Won Lee, Sung-Bae Kim, Jae Ho Jeong,,
Breast Cancer Research and Treatment10.1007/s10549-017-4162-320171632303-310Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER databaseMegan C. Roberts, Dave P. Miller, Steven Shak, Valentina I. Petkov,,
Journal of the Egyptian National Cancer Institute10.1186/s43046-020-00025-52020321Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control CenterSalah Fayaz, Heba El-Sayed Eissa, Gerges Attia Demian,,